Literature DB >> 16135555

Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.

Davide Calebiro1, Tiziana de Filippis, Simona Lucchi, Cesare Covino, Sara Panigone, Paolo Beck-Peccoz, David Dunlap, Luca Persani.   

Abstract

TSH resistance is one of the causes of congenital hypothyroidism with thyroid gland in situ. We recently identified families with dominant transmission of partial TSH resistance due to heterozygous inactivating mutations in TSH receptor (TSHR) gene. Although we documented a poor routing of TSHR mutants to the cell membrane, the mechanism responsible for dominant inheritance of partial TSH resistance remained unexplained. We therefore co-transfected Cos-7 cells with wild-type TSHR and mutant receptors found in these patients. A variable impairment of cAMP response to bTSH stimulation was observed, suggesting that inactive TSHR mutants can exert a dominant negative effect on wild-type TSHR. We then generated chimeric constructs of wild-type or inactive TSHR mutants fused to different reporters. By fluorescence microscopy and immunoblotting, we documented an intracellular entrapment, mainly in the endoplasmic reticulum, and reduced maturation of wild-type TSHR in the presence of inactive TSHR mutants. Finally, fluorescence resonance energy transfer and co-immunoprecipitation experiments were performed to study the molecular interactions between wild-type and mutant TSHRs. The results are in agreement with the presence of oligomers formed by wild-type and mutant receptors in the endoplasmic reticulum. Such physical interaction represents the molecular basis for the dominant negative effect of inactive TSHR mutants. These findings provide an explanation for the dominant transmission of partial TSH resistance. This is the first report linking dominant negative mutations of a G protein-coupled receptor to an abnormal endocrine phenotype in heterozygous patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135555     DOI: 10.1093/hmg/ddi329

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  The coexistence of a novel inactivating mutant thyrotropin receptor allele with two thyroid peroxidase mutations: a genotype-phenotype correlation.

Authors:  Chutintorn Sriphrapradang; Yardena Tenenbaum-Rakover; Mia Weiss; Marla S Barkoff; Osnat Admoni; Dallasheh Kawthar; Gianluigi Caltabiano; Leonardo Pardo; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2011-04-13       Impact factor: 5.958

Review 3.  A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization.

Authors:  G Milligan
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

4.  Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.

Authors:  Fabien M Décaillot; Raphael Rozenfeld; Achla Gupta; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

5.  Secretin receptor oligomers form intracellularly during maturation through receptor core domains.

Authors:  Cayle S Lisenbee; Laurence J Miller
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

Review 6.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

Review 7.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

8.  Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor.

Authors:  Joseph E Mazurkiewicz; Katharine Herrick-Davis; Margarida Barroso; Alfredo Ulloa-Aguirre; Barbara Lindau-Shepard; Richard M Thomas; James A Dias
Journal:  Biol Reprod       Date:  2015-03-11       Impact factor: 4.285

Review 9.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

10.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.